OmniAb (OABI) Debt to Equity (2021 - 2026)

OmniAb (OABI) reported Debt to Equity of $0.0 for Q1 2026, up 195.6% year-over-year from $0.0 in Q1 2025, and down 2.42% quarter-over-quarter from $0.0 in Q4 2025.

OmniAb (OABI) Debt to Equity (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Debt to Equity data on file, last reported at $0.0 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.0, up 195.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.0 (up 195.6% YoY), and the FY2025 annual result was $0.0, up 111.77% from the prior year.
  • Debt to Equity retreated to $0.0 in Q1 2026 per OABI's latest filing, from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.01 in Q4 2022 and troughed at $0.0 in Q1 2022.
  • A 5-year average of $0.0 and a median of $0.0 in 2024 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2023 and 2024: Debt to Equity soared 3725.38% in 2023, then plunged 86.76% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.01 in 2022, then slumped by 64.84% to $0.0 in 2023, then tumbled by 55.43% to $0.0 in 2024, then soared by 111.77% to $0.0 in 2025, then declined by 2.42% to $0.0 in 2026.
  • Business Quant data shows OABI's Debt to Equity at $0.0 in Q1 2026, $0.0 in Q4 2025, and $0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Jun 30, 2021 0.00